Dolby Laboratories, Inc. (DLB) P/E Ratio History
Deep ValueTrading at 19.1x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2005–2026
Loading P/E history...
P/E Ratio Analysis
As of July 7, 2026, Dolby Laboratories, Inc. (DLB) trades at a price-to-earnings ratio of 19.1x, with a stock price of $50.04 and trailing twelve-month earnings per share of $2.55.
The current P/E is 44% below its 5-year average of 34.0x. Over the past five years, DLB's P/E has ranged from a low of 22.9x to a high of 44.7x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 29.6x, DLB trades at a 36% discount to its sector peers. The sector includes 358 companies with P/E ratios ranging from 0.0x to 194.0x.
The PEG ratio of 6.18 (P/E divided by -3% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, DLB trades at a notable discount to the S&P 500 median P/E of 25.6x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DLB DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DLB Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
DLB P/E vs Peers
Vertical Software and Industry Platforms peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $6B | 49.6 | - | +13% | |
| $4B | 143.4 | - | +118%Best | |
| $197B | 37.2 | 17.90 | -44% | |
| $7B | 24.0 | 0.46 | -2% | |
| $2B | 12.8Lowest | 0.37Best | +9% | |
| $14B | 20.3 | - | +16% | |
| $4.6T | 41.9 | 2.35 | +23% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
DLB Historical P/E Data (2005–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | Mar 27 2026 | $58.03 | $2.53 | 22.9x | -20% |
| FY2026 Q1 | Dec 26 2025 | $65.71 | $2.48 | 26.5x | -8% |
| FY2025 Q4 | Sep 26 2025 | $72.39 | $2.63 | 27.5x | -4% |
| FY2025 Q3 | Jun 27 2025 | $74.05 | $2.73 | 27.1x | -6% |
| FY2025 Q2 | Mar 28 2025 | $79.91 | $2.65 | 30.2x | +5% |
| FY2025 Q1 | Dec 27 2024 | $78.48 | $2.72 | 28.9x | +0% |
| FY2024 Q4 | Sep 27 2024 | $75.61 | $2.71 | 27.9x | -3% |
| FY2024 Q3 | Jun 28 2024 | $79.23 | $2.19 | 36.2x | +26% |
| FY2024 Q2 | Mar 29 2024 | $83.77 | $1.96 | 42.7x | +48% |
| FY2024 Q1 | Dec 29 2023 | $86.18 | $1.93 | 44.7x | +55% |
| FY2023 Q4 | Sep 29 2023 | $79.26 | $2.06 | 38.5x | +34% |
| FY2023 Q3 | Jun 30 2023 | $83.68 | $2.25 | 37.2x | +29% |
| FY2023 Q2 | Mar 31 2023 | $85.42 | $2.47 | 34.6x | +20% |
| FY2023 Q1 | Dec 30 2022 | $70.54 | $1.85 | 38.1x | +32% |
| FY2022 Q4 | Sep 30 2022 | $65.15 | $1.80 | 36.2x | +26% |
| FY2022 Q3 | Jul 01 2022 | $70.82 | $1.94 | 36.5x | +27% |
| FY2022 Q2 | Apr 01 2022 | $79.09 | $2.07 | 38.2x | +33% |
| FY2022 Q1 | Dec 31 2021 | $95.22 | $2.44 | 39.0x | +35% |
| FY2021 Q4 | Sep 24 2021 | $92.47 | $2.97 | 31.1x | +8% |
| FY2021 Q3 | Jun 25 2021 | $100.06 | $2.81 | 35.6x | +24% |
| FY2021 Q2 | Mar 26 2021 | $98.22 | $2.95 | 33.3x | +16% |
| FY2021 Q1 | Dec 25 2020 | $95.28 | $3.08 | 30.9x | +7% |
| FY2020 Q4 | Sep 25 2020 | $64.99 | $2.25 | 28.9x | +0% |
| FY2020 Q3 | Jun 26 2020 | $65.76 | $2.42 | 27.2x | -6% |
| FY2020 Q2 | Mar 27 2020 | $53.94 | $2.14 | 25.2x | -12% |
| FY2020 Q1 | Dec 27 2019 | $68.34 | $1.98 | 34.5x | +20% |
| FY2019 Q4 | Sep 27 2019 | $63.79 | $2.44 | 26.1x | -9% |
| FY2019 Q3 | Jun 28 2019 | $64.60 | $2.48 | 26.0x | -10% |
| FY2019 Q2 | Mar 29 2019 | $62.97 | $2.88 | 21.9x | -24% |
| FY2019 Q1 | Dec 28 2018 | $60.83 | $2.84 | 21.4x | -26% |
| FY2018 Q4 | Sep 28 2018 | $69.97 | $1.11 | 63.0x | +119% |
| FY2018 Q3 | Jun 29 2018 | $61.69 | $0.85 | 72.6x | +152% |
| FY2018 Q2 | Mar 30 2018 | $63.56 | $0.80 | 79.5x | +176% |
| FY2018 Q1 | Dec 29 2017 | $62.00 | $0.63 | 98.4x | +242% |
| FY2017 Q4 | Sep 29 2017 | $57.52 | $1.94 | 29.6x | +3% |
| FY2017 Q3 | Jun 30 2017 | $48.96 | $1.96 | 25.0x | -13% |
| FY2017 Q2 | Mar 31 2017 | $52.41 | $1.85 | 28.3x | -2% |
| FY2017 Q1 | Dec 30 2016 | $45.19 | $2.02 | 22.4x | -22% |
| FY2016 Q4 | Sep 30 2016 | $54.29 | $1.81 | 30.0x | +4% |
| FY2016 Q3 | Jul 01 2016 | $47.64 | $2.01 | 23.7x | -18% |
| FY2016 Q2 | Apr 01 2016 | $43.37 | $1.73 | 25.1x | -13% |
| FY2016 Q1 | Jan 01 2016 | $33.65 | $1.63 | 20.6x | -28% |
| FY2015 Q4 | Sep 25 2015 | $31.40 | $1.73 | 18.2x | -37% |
| FY2015 Q3 | Jun 26 2015 | $40.34 | $1.74 | 23.2x | -20% |
| FY2015 Q2 | Mar 27 2015 | $38.10 | $1.78 | 21.4x | -26% |
| FY2015 Q1 | Dec 26 2014 | $44.17 | $1.95 | 22.7x | -21% |
| FY2014 Q4 | - | $41.79 | $1.98 | 21.1x | -27% |
| FY2014 Q3 | Jun 27 2014 | $42.18 | $1.98 | 21.3x | -26% |
| FY2014 Q2 | Mar 28 2014 | $44.39 | $1.89 | 23.5x | -18% |
| FY2014 Q1 | Dec 27 2013 | $38.38 | $1.76 | 21.8x | -24% |
| FY2013 Q4 | Sep 27 2013 | $34.39 | $1.83 | 18.8x | -35% |
| FY2013 Q3 | Jun 28 2013 | $33.45 | $1.88 | 17.8x | -38% |
| FY2013 Q2 | Mar 29 2013 | $33.56 | $2.07 | 16.2x | -44% |
| FY2013 Q1 | Dec 28 2012 | $28.98 | $2.28 | 12.7x | -56% |
| FY2012 Q4 | Sep 28 2012 | $32.75 | $2.45 | 13.4x | -54% |
| FY2012 Q3 | Jun 29 2012 | $41.30 | $2.66 | 15.5x | -46% |
| FY2012 Q2 | Mar 30 2012 | $38.06 | $2.73 | 13.9x | -52% |
| FY2012 Q1 | Dec 30 2011 | $30.51 | $2.64 | 11.6x | -60% |
| FY2011 Q4 | Sep 30 2011 | $27.44 | $2.73 | 10.1x | -65% |
| FY2011 Q3 | Jul 01 2011 | $43.15 | $2.60 | 16.6x | -42% |
| FY2011 Q2 | Apr 01 2011 | $48.25 | $2.60 | 18.6x | -36% |
| FY2011 Q1 | Dec 31 2010 | $66.70 | $2.62 | 25.5x | -12% |
| FY2010 Q4 | Sep 24 2010 | $61.74 | $2.45 | 25.2x | -13% |
| FY2010 Q3 | Jun 25 2010 | $66.46 | $2.26 | 29.4x | +2% |
| FY2010 Q2 | Mar 26 2010 | $59.19 | $2.15 | 27.5x | -4% |
| FY2010 Q1 | Dec 25 2009 | $47.48 | $2.01 | 23.6x | -18% |
| FY2009 Q4 | Sep 25 2009 | $37.99 | $2.10 | 18.1x | -37% |
| FY2009 Q3 | Jun 26 2009 | $36.70 | $2.14 | 17.1x | -40% |
| FY2009 Q2 | Mar 27 2009 | $34.02 | $2.10 | 16.2x | -44% |
| FY2009 Q1 | Dec 26 2008 | $32.22 | $1.99 | 16.2x | -44% |
| FY2008 Q4 | Sep 26 2008 | $36.04 | $1.73 | 20.8x | -28% |
| FY2008 Q3 | Jun 27 2008 | $39.35 | $1.70 | 23.1x | -20% |
| FY2008 Q2 | Mar 28 2008 | $35.20 | $1.56 | 22.6x | -22% |
| FY2008 Q1 | Dec 28 2007 | $50.40 | $1.41 | 35.7x | +24% |
| FY2007 Q4 | Sep 28 2007 | $34.82 | $1.26 | 27.6x | -4% |
| FY2007 Q3 | Jun 29 2007 | $35.41 | $1.09 | 32.5x | +13% |
| FY2007 Q2 | Mar 30 2007 | $34.51 | $1.00 | 34.5x | +20% |
| FY2007 Q1 | Dec 29 2006 | $31.02 | $0.91 | 34.1x | +18% |
| FY2006 Q4 | Sep 29 2006 | $19.85 | $0.80 | 24.8x | -14% |
| FY2006 Q3 | Jun 30 2006 | $23.30 | $0.74 | 31.5x | +9% |
| FY2006 Q2 | Mar 31 2006 | $20.90 | $0.70 | 29.9x | +4% |
| FY2006 Q1 | Dec 30 2005 | $17.05 | $0.55 | 31.0x | +8% |
| FY2005 Q4 | Sep 30 2005 | $16.00 | $0.50 | 32.0x | +11% |
Average P/E for displayed period: 28.8x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DLB — Frequently Asked Questions
Quick answers to the most common questions about buying DLB stock.
What is DLB's P/E ratio?
Dolby Laboratories, Inc. (DLB) trailing twelve-month P/E ratio is 19.1x, based on TTM diluted EPS of $2.55. The 5-year average P/E is 34.0x and the historical range spans 22.9x to 44.7x.
Is DLB stock overvalued or undervalued?
DLB trades at 19.1x P/E, below its 5-year average of 34.0x. At the 0th percentile of its historical range (22.9x–44.7x), the stock is priced at a discount to its own history.
Is DLB stock expensive?
No, DLB is not expensive on a historical basis. The current P/E of 19.1x is below the 5-year average of 34.0x and sits at the 0th percentile of its valuation range.
What is DLB's historical P/E range?
Over the past 5 years, DLB's P/E ratio has ranged from 22.9x to 44.7x, with a median of 36.2x and an average of 34.0x. The current P/E of 19.1x places the stock at the 0th percentile of this range. Full historical data spans 2005–2026.
How does DLB's P/E compare to the S&P 500?
DLB trades at 19.1x P/E versus the S&P 500 median of 25.6x. The 25% discount to the market suggests lower growth expectations or perceived higher risk.
How does DLB's valuation compare to Technology peers?
Dolby Laboratories, Inc. P/E of 19.1x compares to the Technology sector median of 29.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is DLB's PEG ratio?
DLB PEG ratio is 6.18, based on a P/E of 19.1x and EPS growth of -2.6%. A PEG above 2.0 indicates a premium valuation relative to earnings growth — typically considered expensive.
What is DLB's earnings yield?
DLB earnings yield is 5.24%, the inverse of its 19.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.